VANGUARD CAPITAL MANAGEMENT LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 2100119
MALVERN, PA
Position in CATX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,260,246
New position
Shares Held
4,378,956
first reported quarter
Ownership
3.84%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Medical Devices
Healthcare · as of Mar 31, 2026VANGUARD CAPITAL MANAGEMENT LLC holds $46,403,555,066 across 110 Medical Devices names. CATX ranks #45 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
112,949,933 | $11,596,569,621 | |
| 2 | SYK |
Stryker Corp
|
22,383,181 | $7,354,889,444 | |
| 3 | MDT |
Medtronic plc
|
83,333,833 | $7,220,876,629 | |
| 4 | BSX |
Boston Scientific Corp
|
96,411,568 | $6,049,825,892 | |
| 5 | EW |
Edwards Lifesciences Corp
|
37,727,792 | $3,021,241,583 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
28,864,188 | $2,054,552,901 | |
| 7 | DXCM |
Dexcom Inc
|
25,020,961 | $1,571,316,350 | |
| 8 | STE |
STERIS plc
|
6,366,378 | $1,407,797,167 |
All Filings in CATX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,260,246 | 4,378,956 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||